Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Cue Biopharma, Inc. (CUE)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  1.214.93.23.51.10.00.00.0
            Revenue growth  -91.7%373.7%-8.8%202.7%    
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  1.214.93.23.51.10.00.00.0
            Gross margin  100.0%100.0%100.0%100.0%100.0%   
Selling, general and administrative   [+]54.558.748.212.711.34.32.00.4
Research and development     27.528.518.95.71.5
Other operating expenses  -0.4-0.10.1     
EBITDA   [+]-51.9-42.4-44.1-36.0-37.9-22.8-7.5-1.9
            EBITDA margin  -4165.8%-283.5%-1397.6%-1039.8%-3320.2%   
Depreciation  0.91.31.10.80.80.40.20.0
EBITA  -52.8-43.6-45.1-36.8-38.7-23.2-7.7-1.9
            EBITA margin  -4239.9%-291.9%-1431.1%-1062.9%-3386.7%   
Amortization of intangibles     0.0    
EBIT   [+]-52.8-43.6-45.1-36.8-38.7-23.2-7.7-1.9
            EBIT margin  -4239.9%-291.9%-1431.1%-1063.2%-3386.7%   
Interest income     0.50.40.0  
Other income (expense), net  -0.20.00.6 0.5 0.0 
Pre-tax income  -53.0-43.7-44.6-36.3-38.2-23.2-7.7-1.9
Income taxes  0.00.50.20.40.80.00.00.0
            Tax rate  0.0%    0.0%0.0%0.0%
Net income  -53.0-44.2-44.8-36.7-39.0-23.2-7.7-1.9
            Net margin  -4257.1%-295.6%-1419.8%-1061.2%-3411.5%   
   
Basic EPS   [+]($1.49)($1.41)($1.56)($1.66)($1.94)($2.16)($1.03)($0.34)
Diluted EPS   [+]($1.49)($1.41)($1.56)($1.66)($1.94)($2.16)($1.03)($0.34)
   
Shares outstanding (basic)   [+]35.631.328.722.020.110.77.45.7
Shares outstanding (diluted)   [+]35.631.328.722.020.110.77.45.7
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy